BIOREPOSITORY AND MOLECULAR PATHOLOGY SHARED RESOURCE ABSTRACT The Biorepository and Molecular Pathology (BMP) Shared Resource, established in 2000, seamlessly integrates exceptional expertise in biorepository, histology, and molecular diagnostic services for research at Huntsman Cancer Institute (HCI). The College of American Pathologists (CAP)-accredited Biorepository Section provides researchers with high quality, richly annotated fresh tumor, blood, and other body fluids with patient-matched normal controls, using adept procurement, processing, storage, and prioritized distribution. The biorepository is responsible for managing patient consent and IRB approval. Data entry, searches, and annotation of biospecimens with pathology, electronic medical record, genealogical (via the Utah Population Database Shared Resource), genomic (via the High-Throughput Genomics and Bioinformatic Shared Resource), and tumor registry data are all provided via the itBioPath software system used by the BMP Shared Resource (and built by the Research Informatics Shared Resource). The Research Histology Section is separate from hospital histology, facilitating dedicated and rapid turnaround for research. Research Histology performs all manner of expert histology on Biorepository frozen and fixed human and animal tissues, including tissue microarray work, processing, frozen and paraffin sectioning, and special staining from a catalogue of over 175 immuno- and histochemical options. The Molecular Diagnostic Section provides an essential bridge from scientific discovery to patient trials prior to CLIA test certification. It uses biospecimens and histologic preparations from the other two BMP sections for nucleic acid isolation and genetic analysis via Sequenom MassArray and Illumina MiSeq technologies. Data are uploaded to GNomEx, HCI's centralized genomics database. The BMP Shared Resource is directed by Evin Gulbahce, MD, who oversees daily operations and provides essential, pathologist-specific expertise to the Resource. The BMP resides partially in the Cancer Hospital adjacent to pathology/operating rooms to facilitate rapid fresh tissue banking, with the Biorepository section on the third floor of the research building directly adjacent to laboratories. The BMP Shared Resource markedly advances efficiency and cost savings for cancer research at HCI, providing precious, highly annotated biospecimens, histology, and molecular diagnostics which add substantial value to HCI's research efforts and advance HCI?s goals to improve cancer diagnosis, treatment, and cure. The importance of the Resource is demonstrated by its wide array of users and its contributions to numerous publications. In 2013, use of the Resource by Cancer Center investigators with peer-reviewed funding exceeded 43%, while the CCSG budget request is only 6% ($61,944) of the total proposed budget.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-28
Application #
9273912
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2017-05-01
Budget End
2018-04-30
Support Year
28
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Rogers, R Aaron; Fleming, Aaron M; Burrows, Cynthia J (2018) Unusual Isothermal Hysteresis in DNA i-Motif pH Transitions: A Study of the RAD17 Promoter Sequence. Biophys J 114:1804-1815
Tavtigian, Sean V; Greenblatt, Marc S; Harrison, Steven M et al. (2018) Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet Med 20:1054-1060
Wei, Xiaomu; Calvo-Vidal, M Nieves; Chen, Siwei et al. (2018) Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma. Cancer Res 78:2747-2759
Rogers, R Aaron; Fleming, Aaron M; Burrows, Cynthia J (2018) Rapid Screen of Potential i-Motif Forming Sequences in DNA Repair Gene Promoters. ACS Omega 3:9630-9635
Barrott, Jared J; Illum, Benjamin E; Jin, Huifeng et al. (2018) Paracrine osteoprotegerin and ?-catenin stabilization support synovial sarcomagenesis in periosteal cells. J Clin Invest 128:207-218
Sample, Danielle C; Samadder, N Jewel; Pappas, Lisa M et al. (2018) Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol 18:115
Madsen, Michael J; Knight, Stacey; Sweeney, Carol et al. (2018) Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15. Cancer Epidemiol Biomarkers Prev 27:644-652
Delker, Don A; Wood, Austin C; Snow, Angela K et al. (2018) Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia. Cancer Prev Res (Phila) 11:4-15
Wu, Yelena P; Parsons, Bridget G; Mooney, Ryan et al. (2018) Barriers and Facilitators to Melanoma Prevention and Control Behaviors Among At-Risk Children. J Community Health 43:993-1001
Trott, Daniel W; Henson, Grant D; Ho, Mi H T et al. (2018) Age-related arterial immune cell infiltration in mice is attenuated by caloric restriction or voluntary exercise. Exp Gerontol 109:99-107

Showing the most recent 10 out of 1193 publications